Gadolinium-based contrast media may be nephrotoxic even at approved doses

European Radiology

Volumn 14, Issue 9, 2004, Pages 1654-1656

  Thomsen, Henrik S ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Contrast media; Contrast medium induced nephropathy; Gadolinium based contrast media

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CONTRAST MEDIUM; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; GADODIAMIDE; IOHEXOL;

AGED; ANURIA; ARTICLE; BLOOD VESSEL OCCLUSION; CASE REPORT; CORONARY ARTERY ATHEROSCLEROSIS; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIALYSIS; DIARRHEA; EDEMA; FEVER; HEADACHE; HEART FAILURE; HEART SURGERY; HUMAN; HYDRONEPHROSIS; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY ARTERY STENOSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; RISK FACTOR; VOMITING;

AGED; CONTRAST MEDIA; DIABETIC NEPHROPATHIES; DIAGNOSIS, DIFFERENTIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GADOLINIUM; GADOLINIUM DTPA; HUMANS; KIDNEY FAILURE; KIDNEY FUNCTION TESTS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; RENAL ARTERY OBSTRUCTION;

EID: 4544338304     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-004-2379-0     Document Type: Article

References (13)

1. Albrecht T, Dawson P (2000) Gadolinium-DTPA as X-ray contrast medium in clinical studies. Br J Radiol 73:878-882
2. Bittner CA, Goodwin SC, Lu D, McNamara TO, Joseph T (1997) Gadolinium-based contrast agents for angiographic use as a safe radiocontrast in patients with impaired renal function. J Vasc Interv Radiol [Suppl] 8:178
3. Engelbrecht V, Koch JA, Rassek M, Mödder U (1996) Gadodiamide and gadolinium-DTPA as intravenous media in computed tomography. Röfo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 165:24-28
4. Prince MR, Arnoldus C, Frisoli JK (1996) Nephrotoxicity of high-dose gadolinium compared with iodinated contrast. J Magn Reson Imaging 1:162-166
5. Strunk HM, Schild H (2004) Actual use of gadolinium-chelates for non-MRI applications. Eur Radiol 14:1055-1062
6. Thomsen HS, Almén T, Morcos SK, Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (2002) Gadolinium-containing contrast media for radiographic examinations: a position paper. Eur Radiol 12:2600-2605
7. Morcos SK, Thomsen HS, Webb JAW, Contrast Media Safety Committee of the European Society of Urogenital Radiology (1999) Contrast media induced nephrotoxicity: a consensus report. Eur Radiol 9:1602-1613
8. Hansen HP (2003) Diabetic nephropathy. Aspects of pathophysiology and treatment. Dan Med Bull 50:401-422
9. Rudnick MR, Goldfarb S, Wexler L et al (1995) Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. Kidney Int 47:254-261
10. Joffe P, Thomsen HS, Meusel M (1998) The pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency treated conservatively or undergoing hemodialysis or continuous ambulatory peritoneal dialysis. Acad Radiol 5:491-502
11. Berns AS (1989) Nephrotoxicity of contrast media. Kidney Int 36:720-740
12. Sam AD II, Morasch MD, Collins J, Song G, Chen R, Pereles FS (2003) Safety of gadolinium contrast angiography in patients with chronic renal insufficiency. J Vasc Surg 38: 313-318
13. Nyman U, Elmståhl B, Leander P, Nilsson M, Golman K, Almén T (2002) Are gadolinium-based contrast media really safer than iodinated media for digital subtraction angiography in patients with azotemia? Radiology 223:311-318